recombinant mouse mdc Search Results


93
Bio-Techne corporation recombinant mouse ccl22/mdc protein
Recombinant Mouse Ccl22/Mdc Protein, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+mdc/Recombinant+Mouse+CCL22%2FMDC+Protein/bio-techne+corporation___439-md
Average 93 stars, based on 1 article reviews
recombinant mouse ccl22/mdc protein - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
R&D Systems recombinant mouse ccl22
Characterization of engineered porous microspheres loaded with the chemokine <t>CCL22</t> and blank microspheres. (A) Representative SEM image of porous blank microspheres (1000×) (B) Representative SEM image of porous microspheres with CCL22 encapsulated (1000×) (C) A representative particle size distribution obtained using a Coulter Counter shows the Treg-recruiting microspheres. (D) Release Kinetics of CCL22 (Treg-recruiting microspheres) from porous microspheres is shown (n = 3).
Recombinant Mouse Ccl22, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+mdc/Recombinant+Mouse+CCL22%2FMDC+Protein/pmc07805562-46-11-14
Average 90 stars, based on 1 article reviews
recombinant mouse ccl22 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

93
R&D Systems ccl22
A . Differentially expressed genes in unstimulated or LPS or IL-4 stimulated LysM ΔZeb1 compared to LysM Ctrl BMDMs as measured by a customized RT2 array and depicted in log 2 fold change of expression. nd marks non-detectable mRNA levels. All transcripts were normalized to Gapdh (n=3). B . Relative mRNA expression of Ccl2 and <t>Ccl22</t> in LysM Ctrl and LysM ΔZeb1 BMDMs (n=3; means ±SD; 2-way ANOVA). C . Comparison of transcript and secretome alterations of Ccl2 and Ccl22 in LysM ΔZeb1 compared to LysM Ctrl BMDMs (n≥5; means ±SD).
Ccl22, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+mdc/Recombinant+Mouse+CCL22%2FMDC+Protein/bio_rxiv__2024__02__26__582102-281-16-17
Average 93 stars, based on 1 article reviews
ccl22 - by Bioz Stars, 2026-11
93/100 stars
  Buy from Supplier

90
R&D Systems recombinant mouse mdc
FIG. 4. <t>Recombinant</t> mouse <t>MDC</t> (rmMDC) exacerbates lung inflam- mation following hemorrhage and resuscitation (H/R). Representative micrographs of lung tissue stained with hematoxylin-eosin (AYC) and antiYmouse Ly-6B.2 (DYF) for inflammatory cell identification. The lungs from mice injected with rmMDC prior to resuscitation (C, F) had substantial inter- stitial tissue edema and cell infiltration as compared with sham mice (A, D) and mice resuscitated with LR solution only (B, E). G, Quantification of posi- tively stained cells confirmed the effect of rmMDC on increased inflammatory cell recruitment. **P G 0.001 vs. all groups and *P G 0.001 vs. sham.
Recombinant Mouse Mdc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+mdc/Recombinant+Mouse+CCL22%2FMDC+Protein%2C+CF/10__1097_slash_shk__0000000000000253-43-13-16
Average 90 stars, based on 1 article reviews
recombinant mouse mdc - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
R&D Systems murine mdc
FIGURE 1. <t>MDC</t> protects mice from the lethality induced by CLP. The CLP mice were treated with <t>i.p.</t> <t>injection</t> of either MDC (1 mg/mouse; F; 15 mice) or vehicle (E; 15 mice) immediately after CLP. The survival rates were monitored for 7 days after CLP. Two different experiments were conducted, and the data were pooled. The mortality rates were very similar in individual experiments.
Murine Mdc, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+mdc/Recombinant+Mouse+CCL22%2FMDC+Protein%2C+CF/pm10799899-54-15-19
Average 90 stars, based on 1 article reviews
murine mdc - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Kingfisher Biotech mouse ccl22 recombinant protein
FIGURE 1. <t>MDC</t> protects mice from the lethality induced by CLP. The CLP mice were treated with <t>i.p.</t> <t>injection</t> of either MDC (1 mg/mouse; F; 15 mice) or vehicle (E; 15 mice) immediately after CLP. The survival rates were monitored for 7 days after CLP. Two different experiments were conducted, and the data were pooled. The mortality rates were very similar in individual experiments.
Mouse Ccl22 Recombinant Protein, supplied by Kingfisher Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+mdc/Mouse+CCL22+Recombinant+Protein/custom%40rp2267m%4010%2E3390%2Fsu12166293
Average 90 stars, based on 1 article reviews
mouse ccl22 recombinant protein - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

N/A
The Recombinant Mouse CCL22 MDC Protein from R D Systems is derived from E coli The Recombinant Mouse CCL22 MDC Protein has been validated for the following applications Bioactivity
  Buy from Supplier

N/A
MDC/CCL22, Mouse recombinant; 10 ug
  Buy from Supplier

N/A
Recombinant Mouse CCL22 (MDC) (carrier-free) Apps: BA; Size: 10 μg
  Buy from Supplier

N/A
MDC (CCL22), Recombinant Mouse; 5 ug
  Buy from Supplier

N/A
Recombinant Mouse CCL22/MDC Protein
  Buy from Supplier

N/A
Recombinant MDC is a bioactive protein intended for use in cell culture applications. MDC displays chemotactic activity for monocytes, dendritic cells, natural killer cells and for chronically activated T lymphocytes. It also displays a mild
  Buy from Supplier

Image Search Results


Characterization of engineered porous microspheres loaded with the chemokine CCL22 and blank microspheres. (A) Representative SEM image of porous blank microspheres (1000×) (B) Representative SEM image of porous microspheres with CCL22 encapsulated (1000×) (C) A representative particle size distribution obtained using a Coulter Counter shows the Treg-recruiting microspheres. (D) Release Kinetics of CCL22 (Treg-recruiting microspheres) from porous microspheres is shown (n = 3).

Journal: Journal of controlled release : official journal of the Controlled Release Society

Article Title: Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease

doi: 10.1016/j.jconrel.2017.05.007

Figure Lengend Snippet: Characterization of engineered porous microspheres loaded with the chemokine CCL22 and blank microspheres. (A) Representative SEM image of porous blank microspheres (1000×) (B) Representative SEM image of porous microspheres with CCL22 encapsulated (1000×) (C) A representative particle size distribution obtained using a Coulter Counter shows the Treg-recruiting microspheres. (D) Release Kinetics of CCL22 (Treg-recruiting microspheres) from porous microspheres is shown (n = 3).

Article Snippet: Fabrication of microspheres Poly (lactic- co -glycolic) acid (PLGA) microspheres encapsulating recombinant mouse CCL22 (R & D Systems, Minneapolis MN) were formulated according to a previously reported water-oil-water double emulsion technique [ 19 ].

Techniques:

A . Differentially expressed genes in unstimulated or LPS or IL-4 stimulated LysM ΔZeb1 compared to LysM Ctrl BMDMs as measured by a customized RT2 array and depicted in log 2 fold change of expression. nd marks non-detectable mRNA levels. All transcripts were normalized to Gapdh (n=3). B . Relative mRNA expression of Ccl2 and Ccl22 in LysM Ctrl and LysM ΔZeb1 BMDMs (n=3; means ±SD; 2-way ANOVA). C . Comparison of transcript and secretome alterations of Ccl2 and Ccl22 in LysM ΔZeb1 compared to LysM Ctrl BMDMs (n≥5; means ±SD).

Journal: bioRxiv

Article Title: Macrophages foster adaptive anti-tumor immunity by ZEB1-dependent cytotoxic T cell chemoattraction

doi: 10.1101/2024.02.26.582102

Figure Lengend Snippet: A . Differentially expressed genes in unstimulated or LPS or IL-4 stimulated LysM ΔZeb1 compared to LysM Ctrl BMDMs as measured by a customized RT2 array and depicted in log 2 fold change of expression. nd marks non-detectable mRNA levels. All transcripts were normalized to Gapdh (n=3). B . Relative mRNA expression of Ccl2 and Ccl22 in LysM Ctrl and LysM ΔZeb1 BMDMs (n=3; means ±SD; 2-way ANOVA). C . Comparison of transcript and secretome alterations of Ccl2 and Ccl22 in LysM ΔZeb1 compared to LysM Ctrl BMDMs (n≥5; means ±SD).

Article Snippet: Final concentrations of cytokines were 1.93 ng/ ml CCL2 (R&D Systems, 479-JE-050) and 0.18 ng/ ml CCL22 (R&D Systems, 439-MD-025) and of antibodies 5 μg/ml IgG (Diagenode, C15410206), anti-CCL2 (Novus Biologicals, NBP1-07035SS) or anti-CCL22 (abcam, ab124768), respectively.

Techniques: Expressing, Comparison

A-B . Venn diagrams of differentially expressed genes (DEGs) of LysM Ctrl (blue) and LysM ΔZeb1 BMDMs (red) after stimulation with LPS (A) or IL-4 (B) compared to unstimulated in total (left) and divided in up-/downregulated DEGs (right). C . GO term enrichment analysis for DEGs (FDR<0.05) uniquely up- or downregulated by LysM ΔZeb1 BMDMs after LPS stimulation. D . Log 2 fold change of expression of selected trafficking genes after LPS stimulation. X marks no significant deregulation. E . Representative images and quantification of OPP incorporation of LysM Ctrl and LysM ΔZeb1 BMDMs with 0h, 4h and 16h LPS pre-stimulation (n=3; means ±SD; 2-way ANOVA). F-G . Representative arrays of intracellular cytokines of LysM Ctrl and LysM ΔZeb1 BMDMs with LPS stimulation or additional Brefeldin A and Monensin treatment (F) and quantification of intracellular CCL2 and CCL22 after LPS, Brefeldin A and Monensin treatment (G; n≥2).

Journal: bioRxiv

Article Title: Macrophages foster adaptive anti-tumor immunity by ZEB1-dependent cytotoxic T cell chemoattraction

doi: 10.1101/2024.02.26.582102

Figure Lengend Snippet: A-B . Venn diagrams of differentially expressed genes (DEGs) of LysM Ctrl (blue) and LysM ΔZeb1 BMDMs (red) after stimulation with LPS (A) or IL-4 (B) compared to unstimulated in total (left) and divided in up-/downregulated DEGs (right). C . GO term enrichment analysis for DEGs (FDR<0.05) uniquely up- or downregulated by LysM ΔZeb1 BMDMs after LPS stimulation. D . Log 2 fold change of expression of selected trafficking genes after LPS stimulation. X marks no significant deregulation. E . Representative images and quantification of OPP incorporation of LysM Ctrl and LysM ΔZeb1 BMDMs with 0h, 4h and 16h LPS pre-stimulation (n=3; means ±SD; 2-way ANOVA). F-G . Representative arrays of intracellular cytokines of LysM Ctrl and LysM ΔZeb1 BMDMs with LPS stimulation or additional Brefeldin A and Monensin treatment (F) and quantification of intracellular CCL2 and CCL22 after LPS, Brefeldin A and Monensin treatment (G; n≥2).

Article Snippet: Final concentrations of cytokines were 1.93 ng/ ml CCL2 (R&D Systems, 479-JE-050) and 0.18 ng/ ml CCL22 (R&D Systems, 439-MD-025) and of antibodies 5 μg/ml IgG (Diagenode, C15410206), anti-CCL2 (Novus Biologicals, NBP1-07035SS) or anti-CCL22 (abcam, ab124768), respectively.

Techniques: Expressing

A . Confluence of KPC cells alone or co-cultured with LysM Ctrl or LysM ΔZeb1 BMDMs (n=3). B . Representative images at t=28h and quantification over time of KPC cell invasion into a scratch wound without or with co-culture of LysM Ctrl or LysM ΔZeb1 BMDMs (n=3). C . Confluence of KPC cells alone or with LysM Ctrl or LysM ΔZeb1 BMDM conditioned medium (CM) (n=2 KPC CM, n=3 LysM Ctrl and LysM ΔZeb1 CM). D . Transwell migration assay of CD8+ T cells alone or towards LysM Ctrl or LysM ΔZeb1 BMDMs in absence or presence of recombinant CCL2 and CCL22 (left panel, n>3) or absence or presence of anti-CCL2 and anti-CCL22 antibodies (right panel, n=3). Means ±SD; *:p<0.05; **:p<0.01; ns: not significant; 2-way ANOVA.

Journal: bioRxiv

Article Title: Macrophages foster adaptive anti-tumor immunity by ZEB1-dependent cytotoxic T cell chemoattraction

doi: 10.1101/2024.02.26.582102

Figure Lengend Snippet: A . Confluence of KPC cells alone or co-cultured with LysM Ctrl or LysM ΔZeb1 BMDMs (n=3). B . Representative images at t=28h and quantification over time of KPC cell invasion into a scratch wound without or with co-culture of LysM Ctrl or LysM ΔZeb1 BMDMs (n=3). C . Confluence of KPC cells alone or with LysM Ctrl or LysM ΔZeb1 BMDM conditioned medium (CM) (n=2 KPC CM, n=3 LysM Ctrl and LysM ΔZeb1 CM). D . Transwell migration assay of CD8+ T cells alone or towards LysM Ctrl or LysM ΔZeb1 BMDMs in absence or presence of recombinant CCL2 and CCL22 (left panel, n>3) or absence or presence of anti-CCL2 and anti-CCL22 antibodies (right panel, n=3). Means ±SD; *:p<0.05; **:p<0.01; ns: not significant; 2-way ANOVA.

Article Snippet: Final concentrations of cytokines were 1.93 ng/ ml CCL2 (R&D Systems, 479-JE-050) and 0.18 ng/ ml CCL22 (R&D Systems, 439-MD-025) and of antibodies 5 μg/ml IgG (Diagenode, C15410206), anti-CCL2 (Novus Biologicals, NBP1-07035SS) or anti-CCL22 (abcam, ab124768), respectively.

Techniques: Cell Culture, Co-Culture Assay, Transwell Migration Assay, Recombinant

FIG. 4. Recombinant mouse MDC (rmMDC) exacerbates lung inflam- mation following hemorrhage and resuscitation (H/R). Representative micrographs of lung tissue stained with hematoxylin-eosin (AYC) and antiYmouse Ly-6B.2 (DYF) for inflammatory cell identification. The lungs from mice injected with rmMDC prior to resuscitation (C, F) had substantial inter- stitial tissue edema and cell infiltration as compared with sham mice (A, D) and mice resuscitated with LR solution only (B, E). G, Quantification of posi- tively stained cells confirmed the effect of rmMDC on increased inflammatory cell recruitment. **P G 0.001 vs. all groups and *P G 0.001 vs. sham.

Journal: Shock

Article Title: Macrophage-Derived Chemokine (CCL22) Is a Novel Mediator of Lung Inflammation Following Hemorrhage and Resuscitation

doi: 10.1097/shk.0000000000000253

Figure Lengend Snippet: FIG. 4. Recombinant mouse MDC (rmMDC) exacerbates lung inflam- mation following hemorrhage and resuscitation (H/R). Representative micrographs of lung tissue stained with hematoxylin-eosin (AYC) and antiYmouse Ly-6B.2 (DYF) for inflammatory cell identification. The lungs from mice injected with rmMDC prior to resuscitation (C, F) had substantial inter- stitial tissue edema and cell infiltration as compared with sham mice (A, D) and mice resuscitated with LR solution only (B, E). G, Quantification of posi- tively stained cells confirmed the effect of rmMDC on increased inflammatory cell recruitment. **P G 0.001 vs. all groups and *P G 0.001 vs. sham.

Article Snippet: In separate studies, mice were hemorrhaged and injected intravenously with 1 2g of recombinant mouse MDC (R&D Systems) prior to resuscitation.

Techniques: Recombinant, Staining, Injection

FIGURE 1. MDC protects mice from the lethality induced by CLP. The CLP mice were treated with i.p. injection of either MDC (1 mg/mouse; F; 15 mice) or vehicle (E; 15 mice) immediately after CLP. The survival rates were monitored for 7 days after CLP. Two different experiments were conducted, and the data were pooled. The mortality rates were very similar in individual experiments.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response.

doi: 10.4049/jimmunol.164.10.5362

Figure Lengend Snippet: FIGURE 1. MDC protects mice from the lethality induced by CLP. The CLP mice were treated with i.p. injection of either MDC (1 mg/mouse; F; 15 mice) or vehicle (E; 15 mice) immediately after CLP. The survival rates were monitored for 7 days after CLP. Two different experiments were conducted, and the data were pooled. The mortality rates were very similar in individual experiments.

Article Snippet: Immediately after CLP, the mice were treated with either i.p or i.v. injection of recombinant murine MDC (1 mg/mouse; R&D Systems, Minneapolis, MN; endotoxin content , 0.1 ng/mg).

Techniques: Injection

FIGURE 5. MDC blockade reduces survival of mice after CLP. The CLP mice were treated with i.p. injection of either anti-MDC antiserum (F; 30 mice) or control serum (E; 30 mice) 2 h before CLP. The survival rates were monitored for 7 days after CLP. Three different experiments were conducted, and the data were pooled. The mortality rates were very similar in individual experiments.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response.

doi: 10.4049/jimmunol.164.10.5362

Figure Lengend Snippet: FIGURE 5. MDC blockade reduces survival of mice after CLP. The CLP mice were treated with i.p. injection of either anti-MDC antiserum (F; 30 mice) or control serum (E; 30 mice) 2 h before CLP. The survival rates were monitored for 7 days after CLP. Three different experiments were conducted, and the data were pooled. The mortality rates were very similar in individual experiments.

Article Snippet: Immediately after CLP, the mice were treated with either i.p or i.v. injection of recombinant murine MDC (1 mg/mouse; R&D Systems, Minneapolis, MN; endotoxin content , 0.1 ng/mg).

Techniques: Injection, Control

FIGURE 6. MDC induces respiratory burst in macrophages and lyso- zomal enzyme release from macrophages. Peritoneal cells were harvested from normal mice, the cells (1 3 106 cells) were incubated for 2 h at 37°C, and nonadherent cells were removed. A, The adherent macrophages were stimulated with murine MDC. After 30 min, the cultures were assayed for extracellular O2 2 release. B, The adherent macrophages were stimulated with murine MDC for 48 h at 37°C, and then the lysozyme enzyme ac- tivities in the culture supernatant were measured. The data are representa- tive of the three individual experiments (n 5 8 each). p, p , 0.05; ‡, p , 0.01; when compared with control (MDC 5 0 ng/ml).

Journal: Journal of immunology (Baltimore, Md. : 1950)

Article Title: Pivotal role of the CC chemokine, macrophage-derived chemokine, in the innate immune response.

doi: 10.4049/jimmunol.164.10.5362

Figure Lengend Snippet: FIGURE 6. MDC induces respiratory burst in macrophages and lyso- zomal enzyme release from macrophages. Peritoneal cells were harvested from normal mice, the cells (1 3 106 cells) were incubated for 2 h at 37°C, and nonadherent cells were removed. A, The adherent macrophages were stimulated with murine MDC. After 30 min, the cultures were assayed for extracellular O2 2 release. B, The adherent macrophages were stimulated with murine MDC for 48 h at 37°C, and then the lysozyme enzyme ac- tivities in the culture supernatant were measured. The data are representa- tive of the three individual experiments (n 5 8 each). p, p , 0.05; ‡, p , 0.01; when compared with control (MDC 5 0 ng/ml).

Article Snippet: Immediately after CLP, the mice were treated with either i.p or i.v. injection of recombinant murine MDC (1 mg/mouse; R&D Systems, Minneapolis, MN; endotoxin content , 0.1 ng/mg).

Techniques: Incubation, Control